Susquehanna International Group
SEEL

Susquehanna International Group’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Susquehanna International Group’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-27
Closed -$13.3K – 13507
2023
Q3 		$19.3K Buy
27
+13
+93% +$55.7K ﹤0.01% 11609
2023
Q2 		$63.4K Buy
+14
New +$48.6K ﹤0.01% 11228
2023
Q1 		– Sell
-18
Closed -$52.7K – 13701
2022
Q4 		$45.7K Sell
18
-41
-69% -$143K ﹤0.01% 11442
2022
Q3 		$233K Sell
59
-71
-55% -$279K ﹤0.01% 10450
2022
Q2 		$339K Buy
130
+28
+27% +$72.9K ﹤0.01% 9243
2022
Q1 		$329K Buy
102
+49
+92% +$211K ﹤0.01% 10057
2021
Q4 		$334K Buy
53
+22
+71% +$169K ﹤0.01% 10218
2021
Q3 		$291K Buy
31
+7
+29% +$60.2K ﹤0.01% 10671
2021
Q2 		$244K Sell
24
-117
-83% -$1.92M ﹤0.01% 11195
2021
Q1 		$2.7M Buy
+141
New +$1.65M ﹤0.01% 5201
2019
Q4 		– Sell
-5
Closed -$17K – 10847
2019
Q3 		$17K Buy
+5
New +$30.1K ﹤0.01% 9967
2019
Q1 		– Hold
0
– -$7K – 10047
2018
Q4 		– Hold
0
– – – 8769
2015
Q3 		– Hold
0
– -$32K – 10317
2015
Q2 		– Hold
0
– – – 9941
2015
Q1 		– Hold
0
– – – 9205
2014
Q4 		– Hold
0
– – – 9412
2014
Q3 		– Hold
0
– – – 9278
2014
Q2 		– Hold
0
– – – 9655
2014
Q1 		– Hold
0
– – – 8749
2013
Q4 		– Hold
0
– – – 8818
2013
Q3 		– Hold
0
– – – 7867
2013
Q2 		– Hold
0
– – – 6166

Other funds holding SEEL

WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFWC
Strategic Family Wealth Counselors Fairfield, New Jersey $381M AUM 21.36% 1-Year Est. Return

Susquehanna International Group's SEEL Position: Q4 2023 in Review

Susquehanna International Group sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2023, closing a stake of 27 shares — an estimated $13.3K sold.

Susquehanna International Group first reported a position in SEEL in Q3 2019 and held it in 11 quarters. The position peaked at $2.7M in Q1 2021. 32 funds tracked by Wall St. Rank hold SEEL as of Q4 2023.

  • Susquehanna International Group reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 27 Seelos Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $13.3K.
  • Susquehanna International Group first reported a position in Seelos Therapeutics, Inc. Common Stock in Q3 2019 and held it in 11 quarters.
  • Susquehanna International Group's Seelos Therapeutics, Inc. Common Stock position peaked at $2.7M in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.